teaser
↓Article continues below this sponsored advert↓
↑Advertisement↑
Access to innovative medicines for all European patients can only be possible if clear framework conditions for pricing and reimbursement are set at European Union level, according to Mr Rolf Schwanitz, State Secretary at Germany
